| BCBS Highmark Penn Medicare Advantage | Spesolimab (Spevigo) | 2024-01-22 |
| BCBS Highmark Penn Medicare Advantage | Enzyme Replacement Therapies | 2024-01-20 |
| Medicare FCSO | Billing and Coding: Molecular Pathology Procedures (57451) | 2024-01-19 |
| Medicare FCSO | Billing and Coding: Destruction of Malignant Skin Lesions (57638) | 2024-01-19 |
| Medicare Novitas | Billing and Coding: Biomarkers Overview (56541) | 2024-01-19 |
| Medicare NGS | Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians – Medical Policy Article (52825) | 2024-01-16 |
| BCBS Florida Coverage Guidelines | Exon-Skipping Therapy for Duchenne (09-J3000-93) | 2024-01-15 |
| BCBS Florida Coverage Guidelines | Temsirolimus (Torisel®) Injection (09-J2000-08) | 2024-01-15 |
| BCBS Florida Coverage Guidelines | Vosoritide (Voxzogo) (09-J4000-16) | 2024-01-15 |
| Medicare Palmetto | Billing and Coding: Low frequency, non-contact, non-thermal ultrasound (53773) | 2024-01-12 |